PATENT CLAIM ANALYSIS

Application Number: 15876960
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "252100"]

Abstract:
The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.

Claim (Index 124):
The method according to  claim 114  wherein R 4  is H and R 3  is C 1 -C 6  alkyl or cyclopropyl.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 1.54762
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14118170', '15366513', '15026740', '13576798', '14322505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7682355316699954
- 35 USC 102 Novelty (BERT): 0.547308422823772
- Combined Prediction Score: 0.7461428207853731
- Mean Citation Score: 330.90194
- Max Citation Score: 387.18896
- Similarity Product: 270.37280609279634

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test